Calvin Meaney

@deepaRD @kidneymedmgmt …dneymedicationmanagement.nexusipe.org/course/reducin…

@kidneymedmgmt Do you have a link for the module?

With Juneteenth approaching, we’re proud to spotlight our 5-part CE module: Reducing Medication-Related Disparities in Black Persons with Chronic Kidney Disease. This series features the voices of Black individuals living with CKD and the healthcare providers who serve them, sharing firsthand insights and actionable solutions to address long standing disparities in care. #Juneteenth #AKHOMM #NephTwitter

Struggling to manage pain in patients with CKD? This course equips clinicians with tools to address pain holistically. Learn about pain types, safe medication use, and create personalized treatment plans. Sign up now: loom.ly/F0Fgalg #CKDcare #PainManagement

It's time to transition from Cockcroft-Gault to eGFR for medication-related decisions! loom.ly/u70gtwc

Should you use eGFR or Cockcroft-Gault eCrCL for medication dosing? See what our NKF Workgroup has to say. @UMN_Pharmacy @ACPEpharmacy @BPSweb @GTMRxInstitute @pharmacists @kidneymedmgmt @RPANephrology @ASNKidney @ANNAnurses @futurefamilymed @AmDiabetesAssn @kidneymedmgmt

Managing anxiety and depression in chronic kidney disease presents unique challenges. Explore tailored treatment options and learn how to develop effective, patient-centered care plans in this CE module! 🔗 Enroll at loom.ly/CVnkVB8

Heading to ACCP? Don’t miss Drs. Josh Neumiller and Wendy St. Peter's presentation, 'A Systematic Review of Coordinated Care in CKM Conditions' on Saturday, Oct 12 from 11:30 AM to 1:00 PM. Learn about the critical role pharmacists play in coordinated kidney care.

With kidney function decline in CKD, dosage adjustments are crucial to minimize toxicity & ensure medication efficacy. We’re excited to announce our newest module which explores pharmacokinetic changes in CKD & provides practical medication examples. …dneymedicationmanagement.nexusipe.org/module/medicat…

Congratulations to ACCP member Gina M. Prescott and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: accpjournals.onlinelibrary.wiley.com/doi/10.1002/ja…   @JACCPJournal #MakingAnImpact #ACCP #TwitteRx

Congratulations to ACCP member Collin M. Clark and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: accpjournals.onlinelibrary.wiley.com/doi/10.1002/ja…   @JACCPJournal #MakingAnImpact #TwitteRx #ACCP

Did you know that a lab value of 5.1 indicates the onset of high potassium? That's why on May 1, we observe High Potassium Awareness Day, raising awareness about the condition & its management. For insights into managing hyperkalemia, explore our module at shorturl.at/wGX39

Are you interested in advancing pharmacy services in your clinic? Check out our currently enrolling Learning and Action Collaborative, designed to empower clinics like yours with the latest strategies, insights, and best practices in pharmaceutical care. youtu.be/BOS1gMdki9k

@NephroSeeker @Ask_Renal Phenytoin to induce metabolism worked for us pubmed.ncbi.nlm.nih.gov/30830975/

Hey! Does anyone have any experience with prograf overdose (T0=38), tx intervention 2 days ago, pt is anuric As per FDA Prograf it’s not dialyzable @Ask_Renal #askrenal

This study compared urinary biomarkers neutrophil gelatinase-associated lipocalin with kidney injury molecule-1 in critically ill children exposed to vancomycin who did and did not develop AKI as defined by changes in SCr. buff.ly/48jOdUp @NFuscoPharmD @accpnephrprn

Join us in our FREE CE exploring groundbreaking STRATEGIES for advancing care in Black individuals with CKD. From building diverse teams to enhancing medication management, let's empower change in healthcare! 💪 #CKD #HealthEquity #PharmacyEducation" buff.ly/3MdaHxi

Learn about STRATEGIES to improve pharmacoequity, overcome BARRIERS to access medications and utilize tools to improve medication use in Black persons with CKD. 🔗 FREE AKHOMM CE module: buff.ly/3MdaHxi #CKD #pharmacoequity

What are the different MRAs that are commercially available? And what evidence supports their use in patients with kidney disease? 🔗 Learn more at: buff.ly/3QdBRXE #KidneyDisease #TwitteRX #NephTwitter

Hyperkalemia is a significant risk of medications that slow progression of chronic kidney disease. Unfortunately, evidence-based guidelines for managing it is sparse. To learn more about risks, prevention, & treatment, enroll here: …dneymedicationmanagement.nexusipe.org/module/hyperka… #TwitteRX

Honored to have authored the hyperkalemia module, check it out now!

Looking to learn how to slow chronic kidney disease progression? Here’s how in four simple steps. #TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #nephrology #healthcareprofessionals #internalmedicine #primarycare

Teams including pharmacists are highly encouraged to submit proposals! #TwitteRx #AKHOMM #pharmacy